Marie‐Sarah Dilhuydy

Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions

Valentin Goede, Kirsten Fischer, Raymonde Busch et al. · New England Journal of Medicine · 2014 · 1.5K citations · Full text

Results of a Randomized Trial of Chlorambucil Versus Fludarabine for Patients With Untreated Waldenström Macroglobulinemia, Marginal Zone Lymphoma, or Lymphoplasmacytic Lymphoma

Véronique Leblond, S.A. Johnson, Sylvie Chevret et al. · Journal of Clinical Oncology · 2012 · 152 citations

Obinutuzumab (GA101) in relapsed/refractory chronic lymphocytic leukemia: final data from the phase 1/2 GAUGUIN study

Guillaume Cartron, Sophie de Guibert, Marie‐Sarah Dilhuydy et al. · Blood · 2014 · 148 citations

Atrial fibrillation in <scp>CLL</scp> patients treated with ibrutinib. An international retrospective study

Philip A. Thompson, Vincent Lévy, Constantine S. Tam et al. · British Journal of Haematology · 2016 · 125 citations · Full text

Heart Failure, Clinical Consequences, Cardiovascular Pharmacology +16

Prevalence of BTK and PLCG2 mutations in a real-life CLL cohort still on ibrutinib after 3 years: a FILO group study

Anne Quinquenel, Luc‐Matthieu Fornecker, Rémi Letestu et al. · Blood · 2019 · 125 citations · Full text